Park et al. demonstrated that a reduction in the levels of very-long-chain ceramides decreased insulin receptor phosphorylation in the liver and inhibited insulin receptor translocation into DRM, leading to insulin resistance [32]. This evidence concerns the gene INSR and Insulin resistance.